NCT04344353 is a clinical trial in Aortic Calcification Valve, sponsored by Instituto Nacional de Cardiologia Ignacio Chavez.

Who is sponsoring NCT04344353?

NCT04344353 is sponsored by Instituto Nacional de Cardiologia Ignacio Chavez.

What condition does NCT04344353 study?

NCT04344353 studies Aortic Calcification Valve, Aortic Valve Stenosis.

Is NCT04344353 still recruiting?

NCT04344353 is currently completed. Last updated 28 July 2021.

Last reviewed 2021-07-28 · How we verify

NCT04344353

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analysis and Comparative Evaluation of Aortic Calcium by Computed Tomography and Histopathology in Patients With Aortic Stenosis

Completed Last updated 28 July 2021

What this trial tests

trial in Aortic Calcification Valve in 80 participants. Completed in 1 January 2021.

Timeline

1 January 2020

Primary endpoint
1 December 2020

1 January 2021

Quick facts

Lead sponsor	Instituto Nacional de Cardiologia Ignacio Chavez
Status	Completed
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 January 2020
Primary completion	1 December 2020
Estimated completion	1 January 2021
Sites	1 location across Mexico

Conditions studied

Aortic Calcification Valve — all drugs for Aortic Calcification Valve →
Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →

Sponsor

Instituto Nacional de Cardiologia Ignacio Chavez — full company profile →

Who can join

Adults 18 to 90, any sex, with Aortic Calcification Valve or Aortic Valve Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates and compares aortic calcium by computed tomography and histopathology in patients with aortic stenosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Instituto Nacional de Cardiologia Ignacio Chavez trials

Trials by the same sponsor.

NCT06881940 — Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With A · NA · not yet recruiting
NCT06342141 — Empagliflozin for No-reflow Phenomenon in PCI for STEMI · Phase 2 · active not recruiting
NCT06521307 — Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery · NA · not yet recruiting
NCT06584734 — Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients · NA · active not recruiting
NCT06013813 — Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04344353 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Nacional de Cardiologia Ignacio Chavez
Last refreshed: 28 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04344353.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing